本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Nautilus Biotechnolgy, Inc.

0.8200
+0.03704.73%
盘后0.82000.00000.00%14:21 EDT
成交量:10.76万
成交额:8.83万
市值:1.03亿
市盈率:-1.50
高:0.8497
开:0.7870
低:0.7700
收:0.7830
数据加载中...
2025/06/23

重要事件披露

Form 8-K - Current report
2025/05/02

重要事件披露

Form 8-K - Current report
2025/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

重要事件披露

Form 8-K - Current report
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/31

重要事件披露

Form 8-K - Current report
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/29

重要事件披露

Form 8-K - Current report
2024/10/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]